Several compounds designed as bisubstrate analogues of protein farnesyltransferase inhibited the prenyl protein-specific protease Rce1, qualifying them as lead structures for a novel class of non-peptidic, non-prenylic inhibitors of this protease.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0960-894x(00)00685-5 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!